相关实验视频
Updated: Jan 12, 2026

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.5K
蛋白质碳化与患有CKD的患者的死亡率增加和CKD进展有关:来自EQUAL研究的结果
Tilla C Folttmann1,2, Antje M Haas1, Nicholas C Chesnaye3,4
1Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital of Würzburg, Würzburg, Germany.
Clinical kidney journal
|November 6, 2025
概括
在患有晚期慢性病 (CKD) 的老年人中,较高的蛋白质碳amylation (C-Alb) 水平与增加的死亡率和需要透析治疗相关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 生物化学 生物化学
- 心血管医学 心血管医学
背景情况:
- 慢性病 (CKD) 中尿素积累导致蛋白质碳amylation.
- 蛋白质碳amylation 与心血管事件和透析患者的死亡率有关.
研究的目的:
- 调查卡巴胺基 (C-Alb) 和老年晚期CKD患者的死亡率,心血管事件和透析启动之间的联系.
主要方法:
- 一项前性队列研究 (EQUAL) 涉及1117名不接受透析的老年CKD患者 (eGFR≤20毫升/分钟/1.73米2).
- 在基线使用液体染色学和质谱学测量C-Alb.
- 随访5年,多变量分析对混因素进行了调整.
主要成果:
- 平均C-Alb为13.5±6.5mmol/mol;在男性和心力衰竭患者中更高.
- C-Alb与年龄,肌素,尿素正相关,与EGFR负相关.
- 增加的C-Alb与较高的死亡风险相关 (adj. HR 1.92) 和透析开始 (adj. 人力资源1.59) 在这里.
结论:
- 升高的C-Alb水平与老年晚期CKD患者的死亡率增加有关.
- 更高的C-Alb预测了这种人群中需要透析治疗的需要.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
Chronic Kidney Disease I: Introduction
552
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552
Chronic Kidney Disease III: Interprofessional Care
331
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
178
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K

